ATE401342T1 - Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden - Google Patents

Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden

Info

Publication number
ATE401342T1
ATE401342T1 AT99950055T AT99950055T ATE401342T1 AT E401342 T1 ATE401342 T1 AT E401342T1 AT 99950055 T AT99950055 T AT 99950055T AT 99950055 T AT99950055 T AT 99950055T AT E401342 T1 ATE401342 T1 AT E401342T1
Authority
AT
Austria
Prior art keywords
albumin
marker
measurement
detection
detecting
Prior art date
Application number
AT99950055T
Other languages
English (en)
Inventor
David Bar-Or
Edward Lau
Original Assignee
Ischemia Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26799929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE401342(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/165,961 external-priority patent/US6475743B1/en
Application filed by Ischemia Tech Inc filed Critical Ischemia Tech Inc
Application granted granted Critical
Publication of ATE401342T1 publication Critical patent/ATE401342T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating And Analyzing Materials By Characteristic Methods (AREA)
AT99950055T 1998-10-02 1999-10-01 Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden ATE401342T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10296298P 1998-10-02 1998-10-02
US09/165,961 US6475743B1 (en) 1998-10-02 1998-10-02 Marker useful for detection and measurement of free radical damage and method

Publications (1)

Publication Number Publication Date
ATE401342T1 true ATE401342T1 (de) 2008-08-15

Family

ID=26799929

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99950055T ATE401342T1 (de) 1998-10-02 1999-10-01 Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden

Country Status (5)

Country Link
EP (1) EP1117686B1 (de)
AT (1) ATE401342T1 (de)
AU (1) AU6279399A (de)
DE (1) DE69939121D1 (de)
WO (1) WO2000020454A1 (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282369B2 (en) 1998-10-02 2007-10-16 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6461875B1 (en) 1998-10-02 2002-10-08 Ischemia Technologies, Inc. Test for rapid evaluation of ischemic states and kit
US7449338B2 (en) 1998-10-02 2008-11-11 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6475743B1 (en) 1998-10-02 2002-11-05 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
US7070937B1 (en) 1998-10-02 2006-07-04 Ischemia Technologies, Inc. Marker useful for detection and measurement of free radical damage and method
AU769727B2 (en) * 1998-10-02 2004-02-05 Ischemia Technologies, Inc. Tests for the rapid evaluation of ischemic states and kits
US6492179B1 (en) 1998-10-02 2002-12-10 Ischemia Techologies, Inc. Test for rapid evaluation of ischemic states and kit
US7592304B2 (en) 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6787636B1 (en) 2000-07-14 2004-09-07 New Century Pharmaceuticals, Inc. Modified serum albumin with reduced affinity for nickel and copper
US7829072B2 (en) 2000-07-14 2010-11-09 Carter Daniel C Serum albumin compositions for use in cleansing or dermatological products for skin or hair
JP5048201B2 (ja) 2000-08-04 2012-10-17 ディーエムアイ バイオサイエンシズ インコーポレイテッド ジケトピペラジン類の使用方法とジケトピペラジン類を含む組成物
AU2002305731A1 (en) * 2001-05-30 2002-12-09 Ischemia Technology, Inc. Method and system for optically performing an assay to determine a medical condition
US7063782B2 (en) 2001-11-26 2006-06-20 Ischemia Technologies, Inc. Electrochemical detection of ischemia
DK1571970T3 (da) * 2002-10-02 2011-11-28 Dmi Biosciences Inc Diagnose og monitorering af sygdomme
NZ539734A (en) * 2002-10-09 2011-07-29 Dmi Biosciences Inc Diagnosis and monitoring of inflammation, ischemia and appendicitis
CN102210852B (zh) 2003-05-15 2016-10-19 安皮奥制药股份有限公司 T-细胞介导的疾病的治疗
US7074194B2 (en) 2003-05-19 2006-07-11 Ischemia Technologies, Inc. Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
JP5856843B2 (ja) 2008-05-27 2016-02-10 アンピオ ファーマシューティカルズ,インコーポレイテッド ジケトピペラジンを用いた医薬組成物
EP2613786A4 (de) 2010-09-07 2013-10-23 Dmi Acquisition Corp Behandlung von erkrankungen
PH12014500685B1 (en) 2011-10-10 2018-10-03 Ampio Pharmaceuticals Inc Treatment of degenerative joint disease
JP2014530063A (ja) 2011-10-10 2014-11-17 アンピオ ファーマシューティカルズ,インコーポレイテッド 免疫寛容が高められた埋込み型医療用デバイス、ならびに製造方法および埋込み方法
HK1198812A1 (en) 2011-10-28 2015-06-12 Ampio Pharmaceuticals, Inc. Treatment of rhinitis
CA2906864A1 (en) 2013-03-15 2014-09-18 Ampio Pharmaceuticals, Inc. Compositions for the mobilization, homing, expansion and differentiation of stem cells and methods of using the same
EP4066836A1 (de) 2014-08-18 2022-10-05 Ampio Pharmaceuticals, Inc. Behandlung von gelenkerkrankungen
EP3310375A4 (de) 2015-06-22 2019-02-20 Ampio Pharmaceuticals, Inc. Verwendung von niedermolekularen fraktionen von humanem serumalbumin bei der behandlung von erkrankungen
TWI568746B (zh) 2016-07-06 2017-02-01 高雄醫學大學 用以評估自由基產生能力的寡肽及方法

Also Published As

Publication number Publication date
EP1117686A1 (de) 2001-07-25
WO2000020454A1 (en) 2000-04-13
AU6279399A (en) 2000-04-26
EP1117686B1 (de) 2008-07-16
DE69939121D1 (de) 2008-08-28
EP1117686A4 (de) 2005-01-12

Similar Documents

Publication Publication Date Title
DE69939121D1 (de) Verfahren und materialien zum nachweis und zur messung von durch freie radikale verursachten schäden
US5585277A (en) Screening method for identifying ligands for target proteins
DE69607176T2 (de) Verfahren zur quantitativen bestimmung menschlichen akutphasen-serum-amyloid-a-proteins; rekombinantes protein; spezifischer antikörper
DE60118527D1 (de) Sensible und multiplexe diagnostische tests zur proteinanalyse
RU95108591A (ru) Способ определения состояния сепсисного заболевания
CA2480466A1 (en) Detection and/or monitoring of synuclein-related diseases
ATE160875T1 (de) Verfahren zum nachweis und/oder zur bestimmung und/oder zur isolierung von apoptotischen zellen in oder aus einer probe
DE69834719D1 (de) Methode zur diagnose von abnormalem knochenstoffwechsel
Friedman Comparison of four different silver-staining techniques for salivary protein detection in alkaline polyacrylamide gels
EP3102593B1 (de) Fluorometrischer immunoassay zum nachweis von anti-dsdna-antikörpern
WO2015027039A1 (en) Devices and methods related to airway inflammation
JP2007533985A5 (de)
DE60025170D1 (de) Diagnostisches verfahren für asthma
Dukhanina et al. Spectral studies on the calcium‐binding properties of Mts1 protein and its interaction with target protein
JP6961101B2 (ja) ウイルスおよび細菌の感染症を識別するための方法およびデバイス
AU5141798A (en) Methods and reagents for determining protein s
CA2366651A1 (en) A method for detecting megsin protein and use thereof
WO2004082455A3 (en) Method for detecting alzheimer’s disease and corresponding peptides and detection reagents
BR0111975A (pt) Fator, composição, veìculo, ligando, kits de diagnósticos, processos para detectar uma prpsc em uma amostra, e para remover prpsc de material biológico, método para diagnosticar encefalopatias espongiformes humanas transmissìveis e encefalopatias de prìons de animais, e, uso de um fator
AU2007200433B8 (en) Biomolecular toxicity assay
WO1999045388A1 (en) Test for analyzing a sample
JPS5995460A (ja) リューマチ性疾病の検査方法および試験キット
CA2344762A1 (en) Tests for the rapid evaluation of ischemic states and kits
WO2004054431A3 (en) Tests for the rapid evaluation of ischemic states and kits
ATE347108T1 (de) Zusammensetzungen und verfahren zum bestimmen von aa4rp

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties